Acute myeloid leukemia (AML) is an aggressive cancer of the blood forming (hematopoietic) system. Due to the high patient variability of disease dynamics, risk-scoring is an important part of its clinical management. AML is characterized by impaired blood cell formation and the accumulation of so-called leukemic blasts in the bone marrow of patients. Recently, it has been proposed to use counts of blood-producing (hematopoietic) stem cells (HSCs) as a biomarker for patient prognosis. In this work, we use a non-linear mathematical model to provide mechanistic evidence for the suitability of HSC counts as a prognostic marker. Using model analysis and computer simulations, we compare different risk-scores involving HSC quantification. We propose and validate a simple approach to improve risk prediction based on HSC and blast counts measured at the time of diagnosis.
REFERENCES
1.
A.
Mordente
, E.
Meucci
, G. E.
Martorana
, and A.
Silvestrini
, “Cancer biomarkers discovery and validation: State of the art, problems and future perspectives,” in Advances in Cancer Biomarkers (Springer Netherlands, 2015), pp. 9–26.2.
H.
Doehner
, E.
Estey
, D.
Grimwade
, S.
Amadori
, F. R.
Appelbaum
, T.
Buechner
, H.
Dombret
, B. L.
Ebert
, P.
Fenaux
, R. A.
Larson
, R. L.
Levine
, F.
Lo-Coco
, T.
Naoe
, D.
Niederwieser
, G. J.
Ossenkoppele
, M.
Sanz
, J.
Sierra
, M. S.
Tallman
, H.-F.
Tien
, A. H.
Wei
, B.
Lowenberg
, and C. D.
Bloomfield
, “Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
,” Blood
129
, 424
–447
(2017
). 3.
G. W.
Roloff
and E. A.
Griffiths
, “When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
,” Blood Adv.
2
, 3070
–3080
(2018
). 4.
C.
Roellig
, M.
Bornhaeuser
, C.
Thiede
, F.
Taube
, M.
Kramer
, B.
Mohr
, W.
Aulitzky
, H.
Bodenstein
, H.-J.
Tischler
, R.
Stuhlmann
, U.
Schuler
, F.
Stölzel
, M.
von Bonin
, H.
Wandt
, K.
Schäfer-Eckart
, M.
Schaich
, and G.
Ehninger
, “Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: Evaluation of the proposed reporting system
,” J. Clin. Oncol.
29
, 2758
–2765
(2011
). 5.
T.
Herold
, V.
Jurinovic
, A. M. N.
Batcha
, S. A.
Bamopoulos
, M.
Rothenberg-Thurley
, B.
Ksienzyk
, L.
Hartmann
, P. A.
Greif
, J.
Phillippou-Massier
, S.
Krebs
, H.
Blum
, S.
Amler
, S.
Schneider
, N.
Konstandin
, M. C.
Sauerland
, D.
Görlich
, W. E.
Berdel
, B. J.
Wörmann
, J.
Tischer
, M.
Subklewe
, S. K.
Bohlander
, J.
Braess
, W.
Hiddemann
, K. H.
Metzeler
, U.
Mansmann
, and K.
Spiekermann
, “A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia
,” Haematologica
103
, 456
–465
(2017
). 6.
P. A.
Greif
, L.
Hartmann
, S.
Vosberg
, S. M.
Stief
, R.
Mattes
, I.
Hellmann
, K. H.
Metzeler
, T.
Herold
, S. A.
Bamopoulos
, P.
Kerbs
, V.
Jurinovic
, D.
Schumacher
, F.
Pastore
, K.
Braeundl
, E.
Zellmeier
, B.
Ksienzyk
, N. P.
Konstandin
, S.
Schneider
, A.
Graf
, S.
Krebs
, H.
Blum
, M.
Neumann
, C. D.
Baldus
, S. K.
Bohlander
, S.
Wolf
, D.
Görlich
, W. E.
Berdel
, B. J.
Wörmann
, W.
Hiddemann
, and K.
Spiekermann
, “Evolution of cytogenetically normal acute myeloid leukemia during therapy and relapse: An exome sequencing study of 50 patients
,” Clin. Cancer Res.
24
, 1716
–1726
(2018
). 7.
C. G. A. R. Network
, “Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
,” New Engl. J. Med.
368
, 2059
–2074
(2013
). 8.
U.
Bacher
, C.
Haferlach
, W.
Kern
, T.
Haferlach
, and S.
Schnittger
, “Prognostic relevance of FLT3-TKD mutations in AML: The combination matters—An analysis of 3082 patients
,” Blood
111
, 2527
–2537
(2008
). 9.
W.
Wang
, T.
Stiehl
, S.
Raffel
, V. T.
Hoang
, I.
Hoffmann
, L.
Poisa-Beiro
, B. R.
Saeed
, R.
Blume
, L.
Manta
, V.
Eckstein
, T.
Bochtler
, P.
Wuchter
, M.
Essers
, A.
Jauch
, A.
Trumpp
, A.
Marciniak-Czochra
, A. D.
Ho
, and C.
Lutz
, “Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia
,” Haematologica
102
, 1567
–1577
(2017
). 10.
T.
Stiehl
, W.
Wang
, C.
Lutz
, and A.
Marciniak-Czochra
, “Mathematical modeling provides evidence for niche competition in human AML and serves as a tool to improve risk stratification
,” Cancer Res.
80
, 3983
(2020
). 11.
G. M.
Crane
, E.
Jeffery
, and S. J.
Morrison
, “Adult haematopoietic stem cell niches
,” Nat. Rev. Immunol.
17
, 573
–590
(2017
). 12.
K.
Kaushansky
, “Hematopoietic stem cells, progenitors, and cytokines,” in Williams Hematology, edited by K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, J. Prchal, and U. Seligsohn (McGraw-Hill, New York, 2010), pp. 231–249.13.
J.
Liesveld
and M.
Lichtman
, “Acute myelogenous leukemia,” in Williams Hematology, edited by K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, J. Prchal, and U. Seligsohn (McGraw-Hill, New York, 2010), pp. 1095–1103.14.
A. L.
Boyd
, C. J.
Campbell
, C. I.
Hopkins
, A.
Fiebig-Comyn
, J.
Russell
, J.
Ulemek
, R.
Foley
, B.
Leber
, A.
Xenocostas
, T. J.
Collins
, and M.
Bhatia
, “Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs
,” J. Exp. Med.
211
, 1925
–1935
(2014
). 15.
F.
Ishikawa
, S.
Yoshida
, Y.
Saito
, A.
Hijikata
, H.
Kitamura
, S.
Tanaka
, R.
Nakamura
, T.
Tanaka
, H.
Tomiyama
, N.
Saito
, M.
Fukata
, T.
Miyamoto
, B.
Lyons
, K.
Ohshima
, N.
Uchida
, S.
Taniguchi
, O.
Ohara
, K.
Akashi
, M.
Harada
, and L. D.
Shultz
, “Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region
,” Nat. Biotechnol.
25
, 1315
–1321
(2007
). 16.
C.
Lutz
, V. T.
Hoang
, E.
Buss
, and A. D.
Ho
, “Identifying leukemia stem cells – Is it feasible and does it matter?
,” Cancer Lett.
338
, 10
–14
(2013
). 17.
V. T.
Hoang
, E. C.
Buss
, W.
Wang
, I.
Hoffmann
, S.
Raffel
, A.
Zepeda-Moreno
, N.
Baran
, P.
Wuchter
, V.
Eckstein
, A.
Trumpp
, A.
Jauch
, A. D.
Ho
, and C.
Lutz
, “The rarity of ALDH+ is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients
,” Int. J. Cancer
137
, 525
–536
(2015
). 18.
T.
Stiehl
, N.
Baran
, A. D.
Ho
, and A.
Marciniak-Czochra
, “Cell division patterns in acute myeloid leukemia stem-like cells determine clinical course: A model to predict patient survival
,” Cancer Res.
75
, 940
–949
(2015
). 19.
T.
Stiehl
, A. D.
Ho
, and A.
Marciniak-Czochra
, “Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis
,” Sci. Rep.
8
, 2809
(2018
). 20.
T.
Stiehl
, C.
Lutz
, and A.
Marciniak-Czochra
, “Emergence of heterogeneity in acute leukemias
,” Biol. Direct.
11
(1
), 51
(2016
). 21.
T.
Stiehl
, N.
Baran
, A.
Ho
, and A.
Marciniak-Czochra
, “Clonal selection and therapy resistance in acute leukaemias: Mathematical modelling explains different proliferation patterns at diagnosis and relapse
,” J. R. Soc. Interface
11
, 20140079
(2014
). 22.
J. M.
Gerber
, B. D.
Smith
, B.
Ngwang
, H.
Zhang
, M. S.
Vala
, L.
Morsberger
, S.
Galkin
, M. I.
Collector
, B.
Perkins
, M. J.
Levis
, C. A.
Griffin
, S. J.
Sharkis
, M. J.
Borowitz
, J. E.
Karp
, and R. J.
Jones
, “A clinically relevant population of leukemic CD34CD38 cells in acute myeloid leukemia
,” Blood
119
, 3571
–3577
(2012
). 23.
A.
Roch
, S.
Giger
, M.
Girotra
, V.
Campos
, N.
Vannini
, O.
Naveiras
, S.
Gobaa
, and M. P.
Lutolf
, “Single-cell analyses identify bioengineered niches for enhanced maintenance of hematopoietic stem cells
,” Nat. Commun.
8
, 221
(2017
). 24.
J.
Bajaj
, T.
Konuma
, N. K.
Lytle
, H. Y.
Kwon
, J. N.
Ablack
, J. M.
Cantor
, D.
Rizzieri
, C.
Chuah
, V. G.
Oehler
, E. H.
Broome
, E. D.
Ball
, E. H.
van der Horst
, M. H.
Ginsberg
, and T.
Reya
, “CD98-mediated adhesive signaling enables the establishment and propagation of acute myelogenous leukemia
,” Cancer Cell
30
, 792
–805
(2016
). 25.
A.
Marciniak-Czochra
, T.
Stiehl
, and W.
Wagner
, “Modeling of replicative senescence in hematopoietic development
,” Aging
1
, 723
–732
(2009
). 26.
C.
Smith
, “Production, distribution, and fate of neutrophils,” in Williams Hematology, edited by K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, U. Seligsohn, and J. Prchal (McGraw-Hill, 2010), Chap. 69, pp. 891–896.27.
J.
Prchal
, “Production of erythrocytes,” in Williams Hematology, edited by K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, U. Seligsohn, and J. Prchal (McGraw-Hill, 2010), Chap. 31, pp. 435–448.28.
K.
Kaushansky
, “Megakaryopoiesis and thrombopoiesis,” in Williams Hematology, edited by K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, U. Seligsohn, and J. Prchal (McGraw-Hill, 2010), Chap. 113, pp. 1721–1734.29.
S.
Gordon
and A.
Pluddemann
, “Production, distribution, and fate of monocytes and macrophages,” in Williams Hematology, edited by K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, U. Seligsohn, and J. Prchal (McGraw-Hill, 2010), Chap. 61, pp. 1021–1034.30.
A.
Patel
, Y.
Zhang
, J.
Fullerton
, L.
Boelen
, A.
Rongvaux
, A.
Maini
, V.
Bigley
, R.
Flavell
, D.
Gilroy
, B.
Asquith
, D.
Macallan
, and S.
Yona
, “The fate and lifespan of human monocyte subsets in steady state and systemic inflammation
,” J. Exp. Med.
214
, 1913
–1923
(2017
).31.
M.
Lichtman
, “Classification and clinical manifestations of the clonal myeloid disorders,” in Williams Hematology, edited by K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, U. Seligsohn, and J. Prchal (McGraw-Hill, 2010), Chap. 85, pp. 1721–1734.32.
I.
Thornley
, D. R.
Sutherland
, R.
Nayar
, L.
Sung
, M. H.
Freedman
, and H. A.
Messner
, “Replicative stress after allogeneic bone marrow transplantation: Changes in cycling of CD34CD90 and CD34CD90 hematopoietic progenitors
,” Blood
97
, 1876
–1878
(2001
). 33.
W.
Craig
, R.
Kay
, R. L.
Cutler
, and P. M.
Lansdorp
, “Expression of thy-1 on human hematopoietic progenitor cells
,” J. Exp. Med.
177
, 1331
–1342
(1993
). 34.
A.
Marciniak-Czochra
, T.
Stiehl
, A. D.
Ho
, W.
Jäger
, and W.
Wagner
, “Modeling of asymmetric cell division in hematopoietic stem cells—Regulation of self-renewal is essential for efficient repopulation
,” Stem Cells Dev.
18
, 377
–386
(2009
). 35.
A.
Marciniak-Czochra
, A.
Mikelić
, and T.
Stiehl
, “Renormalization group second-order approximation for singularly perturbed nonlinear ordinary differential equations
,” Math. Methods Appl. Sci.
41
, 5691
–5710
(2018
). 36.
T.
Stiehl
and A.
Marciniak-Czochra
, “Characterization of stem cells using mathematical models of multistage cell lineages
,” Math. Comput. Model.
53
, 1505
–1517
(2011
). 37.
J.
Layton
, H.
Hockman
, W.
Sheridan
, and G.
Morstyn
, “Evidence for a novel in vivo control mechanism of granulopoiesis: Mature cell-related control of a regulatory growth factor
,” Blood
74
, 1303
–1307
(1989
). 38.
D.
Metcalf
, “Hematopoietic cytokines
,” Blood
111
, 485
–491
(2008
). 39.
T.
Stiehl
, A. D.
Ho
, and A.
Marciniak-Czochra
, “The impact of CD34 cell dose on engraftment after SCTs: Personalized estimates based on mathematical modeling
,” Bone Marrow Transplant.
49
, 30
–37
(2013
). 40.
B.
Lowenberg
, W.
van Putten
, I. P.
Touw
, R.
Delwel
, and V.
Santini
, “Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia
,” New Engl. J. Med.
328
, 614
–619
(1993
). 41.
T.
Stiehl
, A. D.
Ho
, and A.
Marciniak-Czochra
, “Assessing hematopoietic (stem-) cell behavior during regenerative pressure,” in A Systems Biology Approach to Blood (Springer, New York, 2014), pp. 347–367.42.
H.
Roelofs
, E.
de Pauw
, A.
Zwinderman
, S.
Opdam
, R.
Willemze
, H.
Tanke
, and W.
Fibbe
, “Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation
,” Blood
101
(1
), 358
–362
(2003
). 43.
H.
de Jonge
, P.
Valk
, E.
de Bont
, J.
Schuringa
, G.
Ossenkoppele
, E.
Vellenga
, and G.
Huls
, “Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: Relevance of mutated NPM1 and FLT3-ITD
,” Haematologica
96
, 1310
–1317
(2011
). 44.
T.
Lorenzi
, A.
Marciniak-Czochra
, and T.
Stiehl
, “A structured population model of clonal selection in acute leukemias with multiple maturation stages
,” J. Math. Biol.
79
(5
), 1587
–1621
(2019
). 45.
P.
Desai
, N.
Mencia-Trinchant
, O.
Savenkov
, M. S.
Simon
, G.
Cheang
, S.
Lee
, M.
Samuel
, E. K.
Ritchie
, M. L.
Guzman
, K. V.
Ballman
, G. J.
Roboz
, and D. C.
Hassane
, “Somatic mutations precede acute myeloid leukemia years before diagnosis
,” Nat. Med.
24
, 1015
–1023
(2018
). 46.
S.
Abelson
, G.
Collord
, S. W. K.
Ng
, O.
Weissbrod
, N. M.
Cohen
, E.
Niemeyer
, N.
Barda
, P. C.
Zuzarte
, L.
Heisler
, Y.
Sundaravadanam
, R.
Luben
, S.
Hayat
, T. T.
Wang
, Z.
Zhao
, I.
Cirlan
, T. J.
Pugh
, D.
Soave
, K.
Ng
, C.
Latimer
, C.
Hardy
, K.
Raine
, D.
Jones
, D.
Hoult
, A.
Britten
, J. D.
McPherson
, M.
Johansson
, F.
Mbabaali
, J.
Eagles
, J. K.
Miller
, D.
Pasternack
, L.
Timms
, P.
Krzyzanowski
, P.
Awadalla
, R.
Costa
, E.
Segal
, S. V.
Bratman
, P.
Beer
, S.
Behjati
, I.
Martincorena
, J. C. Y.
Wang
, K. M.
Bowles
, J. R.
Quirós
, A.
Karakatsani
, C. L.
Vecchia
, A.
Trichopoulou
, E.
Salamanca-Fernández
, J. M.
Huerta
, A.
Barricarte
, R. C.
Travis
, R.
Tumino
, G.
Masala
, H.
Boeing
, S.
Panico
, R.
Kaaks
, A.
Krämer
, S.
Sieri
, E.
Riboli
, P.
Vineis
, M.
Foll
, J.
McKay
, S.
Polidoro
, N.
Sala
, K.-T.
Khaw
, R.
Vermeulen
, P. J.
Campbell
, E.
Papaemmanuil
, M. D.
Minden
, A.
Tanay
, R. D.
Balicer
, N. J.
Wareham
, M.
Gerstung
, J. E.
Dick
, P.
Brennan
, G. S.
Vassiliou
, and L. I.
Shlush
, “Prediction of acute myeloid leukaemia risk in healthy individuals
,” Nature
559
, 400
–404
(2018
). 47.
G.
Vassiliou
, J.
Cooper
, R.
Rad
, J.
Li
, S.
Rice
, A.
Uren
, L.
Rad
, P.
Ellis
, R.
Andrews
, R.
Banerjee
, C.
Grove
, W.
Wang
, P.
Liu
, P.
Wright
, M.
Arends
, and A.
Bradley
, “Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
,” Nat. Genet.
43
, 470
–475
(2011
). 48.
L.
Kats
, M.
Reschke
, R.
Taulli
, O.
Pozdnyakova
, K.
Burgess
, P.
Bhargava
, K.
Straley
, R.
Karnik
, A.
Meissner
, D.
Small
, S.
Su
, K.
Yen
, J.
Zhang
, and P.
Pandolfi
, “Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance
,” Cell Stem Cell
14
, 329
–341
(2014
). 49.
L.
Cimmino
, I.
Dolgalev
, Y.
Wang
, A.
Yoshimi
, G.
Martin
, J.
Wang
, V.
Ng
, B.
Xia
, M.
Witkowski
, M.
Mitchell-Flack
, I.
Grillo
, S.
Bakogianni
, D.
Ndiaye-Lobry
, M.
Martín
, M.
Guillamot
, R.
Banh
, M.
Xu
, M.
Figueroa
, R.
Dickins
, O.
Abdel-Wahab
, C. Y.
Park
, A.
Tsirigos
, B.
Neel
, and I.
Aifantis
, “Restoration of TET2 function blocks aberrant self-renewal and leukemia progression
,” Cell
170
, 1079
–1095
(2017
). 50.
D.
Gilliland
and J.
Griffin
, “The roles of FLT3 in hematopoiesis and leukemia
,” Blood
100
, 1532
–1542
(2002
). 51.
J.
Poitras
, D.
Heiser
, L.
Li
, B.
Nguyen
, K.
Nagai
, A.
Duffield
, C.
Gamper
, and D.
Small
, “Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model
,” Oncotarget
7
, 69124
–69135
(2016
). 52.
H.
Modi
, T.
McDonald
, S.
Chu
, J.
Yee
, S.
Forman
, and R.
Bhatia
, “Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
,” Blood
109
, 5411
–5421
(2007
). 53.
C.
Sanden
, M.
Ageberg
, J.
Petersson
, A.
Lennartsson
, and U.
Gullberg
, “Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
,” BMC Cancer
13
, 440
(2013
). 54.
G.
Teschl
, Ordinary Differential Equations and Dynamical Systems
(American Mathematical Society
, 2012
).55.
Y.
Song
, A.
Bahnson
, N.
Hall
, H.
Yu
, H.
Shen
, D.
Koebler
, R.
Houck
, Y.
Xie
, and T.
Cheng
, “Stem cell traits in long-term co-culture revealed by time-lapse imaging
,” Leukemia
24
, 153
–161
(2010
). 56.
K.
Foster
, F.
Lassailly
, F.
Anjos-Afonso
, E.
Currie
, K.
Rouault-Pierre
, and D.
Bonnet
, “Different motile behaviors of human hematopoietic stem versus progenitor cells at the osteoblastic niche
,” Stem Cell Rep.
5
, 690
–701
(2015
). © 2020 Author(s).
2020
Author(s)
You do not currently have access to this content.